參考文獻(xiàn)/References:
[1] 陶可,李虎.CKLF1在關(guān)節(jié)炎發(fā)病過程中作用的研究進(jìn)展[J].國際免疫學(xué)雜志,2020,43(4):419-424.
[2] 劉晶晶,田柳,黃桂華.金納米粒應(yīng)用于關(guān)節(jié)炎治療的研究進(jìn)展[J].藥物生物技術(shù),2017,24(4):373-376.
[3] 沈秀麗,馮杰.硫酸軟骨素治療關(guān)節(jié)炎癥的研究進(jìn)展[J].中國醫(yī)藥指南,2013,11(23):453-455.
[4] KUNNUMAKKARA A B,BORDOLOI D,PADMAVATHI G,et al.Curcumin,the golden nutraceutical:multitargeting for multiple chronic diseases[J].Br J Pharmacol,2017,174(11):1325-1348.
[5] 蔡輝,鄭召嶺,商瑋,等.姜黃素對佐劑性關(guān)節(jié)炎大鼠滑膜病理的影響[J].徐州醫(yī)學(xué)院學(xué)報(bào),2008,28(6):367-369.
[6] HENROTIN Y,CLUTTERBUCK A L,ALLAWAY D,et al.Biological actions of curcumin on articular chondrocytes[J].Osteoarthritis Cartilage,2010,18(2):141-149.
[7] DAILY J W,YANG M,PARK S.Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis:a systematic review and meta-analysis of randomized clinical trials[J].J Med Food,2016,19(8):717-729.
[8] 宮偉彥,張雙慶.姜黃素治療關(guān)節(jié)炎效果的Meta分析[J].中國抗生素雜志,2017,42(1):79-83.
[9] 郝興坤,鄭雨晴,王倩,等.吐溫表面活性劑囊泡對姜黃素的包載作用[J].化學(xué)通報(bào),2021,84(11):1243-1247.
[10] 張永為,李偉平,蔣福升,等.姜黃素結(jié)構(gòu)修飾與生物活性的研究進(jìn)展[J].醫(yī)學(xué)研究雜志,2012,41(7):29-31.
[11] 王存斌,劉曉東,邊樺.姜黃素鎮(zhèn)痛作用及其機(jī)制研究進(jìn)展[J].中國處方藥,2019,17(1):23-24.
[12] 孫肖.基于海藻酸鈉的Pickering乳液及其釋藥行為[D].大連:大連理工大學(xué),2017.
[13] 崔明花,付二花,林貞花,等.姜黃素抗腫瘤藥理作用的研究進(jìn)展[J].中國臨床藥理學(xué)雜志,2021,37(2):186-188.
[14] 吳杰,葉娟,劉剛,等.天然姜黃素類化合物的化學(xué)結(jié)構(gòu)研究概況[J].中國藥房,2015,26(34):4872-4876.
[15] 王征,雷天葵,汪荔,等.姜黃、郁金、莪術(shù)寒熱藥性與姜黃素含量關(guān)系研究[J].中國藥師,2017,20(7):1173-1176.
[16] 張金蘭,李朝霞,黃支隆,等.姜黃素在肺部疾病中的研究進(jìn)展[J].貴州醫(yī)藥,2019,43(1):42-45.
[17] 阮棟,王一冰,蔣守群,等.姜黃素的生物活性及其調(diào)節(jié)動物腸道黏膜屏障功能的分子機(jī)制[J].動物營養(yǎng)學(xué)報(bào),2021,33(4):1801-1810.
[18] 徐春明,劉亞,陳瑩瑩,等.姜黃素生理活性、代謝以及生物利用度的研究進(jìn)展[J].中國食品添加劑,2016(9):203-210.
[19] 高彩芳,夏加璇,朱穎,等.納米技術(shù)在改善中藥有效成分成藥性中的應(yīng)用[J].中草藥,2018,49(12):2754-2762.
[20] 于東,王曉欣,姜如嬌.納米抗腫瘤藥物載體的研究進(jìn)展[J].腫瘤,2018,38(6):603-609.
[21] ZHENG Z,SUN Y,LIU Z,et al.The effect of curcumin and its nanoformulation on adjuvant-induced arthritis in rats[J].Drug Des Devel Ther,2015,9:4931-4942.
[22] NAZ Z,AHMAD F J.Curcumin-loaded colloidal carrier system:formulation optimization, mechanistic insight,ex vivo and in vivo evaluation[J].Int J Nanomedicine,2015,10:4293-307.
[23] 陳帥,孫翠霞,代蕾,等.基于生物來源和納米技術(shù)的姜黃素傳遞載體的研究進(jìn)展[J].中國食品學(xué)報(bào),2019,19(8):294-302.
[24] YEH C C,SU Y H,LIN Y J,et al.Evaluation of the protective effects of curcuminoid(curcumin and bisdemethoxycurcumin)-loaded liposomes against bone turnover in a cell-based model of osteoarthritis[J].Drug Des Devel Ther,2015,9:2285-8300.
[25] LI S,STÖCKL S,LUKAS C,et al.Curcumin-primed human BMSC-derived extracellular vesicles reverse IL-1β-induced catabolic responses of OA chondrocytes by upregulating miR-126-3p[J].Stem Cell Res Ther,2021,12(1):252.
[26] 朱雨晴,劉偉,陳興,等.葉酸-殼聚糖修飾姜黃素納米脂質(zhì)體的制備及其性質(zhì)[J].食品科學(xué),2018,39(24):7-13.
[27] 李杰.Cur-HA納米膠束的制備及對RA疾病治療作用的研究[D].蘭州:蘭州大學(xué),2017.
[28] 楊波,劉蘭蘭,段少峰.水溶性姜黃素納米粒的制備[J].河南大學(xué)學(xué)報(bào)(醫(yī)學(xué)版),2019,38(1):6-9.
[29] 張鷹,賈帥軍,田方,等.磷酸鈣骨水泥復(fù)合透明質(zhì)酸-姜黃素對成骨細(xì)胞增殖及成骨能力影響的研究[J].中國修復(fù)重建外科雜志,2021,35(1):104-110.
[30] WANG J,WANG X,CAO Y,et al.Therapeutic potential of hyaluronic acid/chitosan nanoparticles for the delivery of curcuminoid in knee osteoarthritis and an in vitro evaluation in chondrocytes[J].Int J Mol Med,2018,42(5):2604-2614.
[31] ABBAS H,EL-DEEB N M,ZEWAIL M.PLA-coated Imwitor 900 K-based herbal colloidal carriers as novel candidates for the intra-articular treatment of arthritis[J].Pharm Dev Technol,2021,26(6):682-692.
[32] YAN F,LI H,ZHONG Z,et al.Co-delivery of prednisolone and curcumin in human serum albumin nanoparticles for effective treatment of rheumatoid arthritis[J].Int J Nanomedicine,2019,14:9113-9125.
[33] ZHOU Z,GONG F,ZHANG P,et al.Natural product curcumin-based coordination nanoparticles for treating osteoarthritis via targeting Nrf2 and blocking NLRP3 inflammasome[J].Nano Research,2022,15(4):3338-3345.
(收稿日期:2022-05-24 本文編輯:楊雅)